C
Cyclacel Pharmaceuticals (CYCC)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Cyclacel Pharmaceuticals (CYCC)
Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing cancer medicines based on cell cycle, transcriptional regulation and mitosis control biology. The transcriptional regulation program is... Read more
- USD0.34
- USD0.34
- USD0.25
- USD39.84
- -91.50%
- 0M
- 7.42M
- 1.29M
- 9M
- 0.29
- -98.90%
Stock News
1 hour ago
DSW parent is the latest shoemaker to pull its outlook. The stock falls hard despite low expectations.
MarketWatch
2 hours ago
Disney CEO Bob Iger says taking full control of Hulu unlocks new level of growth
CNBC
3 hours ago
Meta Platforms ups the ante in the AI race, and Wells Fargo sees 'green shoots' in a key business
CNBC
4 hours ago
3 Promising Penny Stocks With Market Caps Over $100M
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
